Global injection pen market expected to generate revenue of around USD 46110.73 million by end of 2024, growing at a CAGR of around 5.8% between 2018 and 2024. Injection pen is specifically designed medical devices used for the drug delivery in various chronic conditions and treatment.

Sarasota, FL -- (SBWire) -- 10/03/2018 --Zion Market Research has published a new report titled "Injection Pen Market by Type (Disposable and Reusable Pens), by Therapy (Growth Hormone Therapy, Osteoporosis, Fertility, Diabetes, and Other Therapies), and by End User (Hospitals and Home care): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024". According to the report, global injection pen market was valued at approximately USD 31074.37 million in 2017 and is expected to generate revenue of around USD 46110.73 million by end of 2024, growing at a CAGR of around 5.8% between 2018 and 2024.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/injection-pen-market

Injection pen is specifically designed medical devices used for the drug delivery in various chronic conditions and treatment. It is generally used for frequent self-administration of drugs. These injections pens are easy and convenient to use and it is increasing trend of home health care. Also, it is the most preferred drug delivery methods opted by patients and healthcare providers. As compared to conventional methods, it is more convenient to use and accurate amount of drugs can be easily injected into the patient body based on his/her weight. There are the various technological advancement and FDA approvals in the market which supports the growth of the market and social acceptability among people will also maintain the growth of the injection pen market.

The injection pen market is primarily driven by the increased prevalence of chronic disorders such as diabetes, rheumatoid arthritis, hepatitis, osteoporosis, and others are expected to support the growth of the injection pen market over the forecast period. As per the Rheumatoid Arthritis Support Network report, there were around 1.3 million Americans affected by rheumatoid arthritis and around 1% of the total population worldwide. Moreover, increased acceptance of advanced technology in injection pen and FDA approvals are expected to promote the growth of the injection pen market over the forecast period. Furthermore, the increased demand from the healthcare industry for safer and advanced drug delivery method over a period of time is expected to support the growth of the injection pen market. However, alternative methods for drug delivery and poor reimbursement policies are expected to inhibit the growth of the injection pen market over the forecast period.

Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/injection-pen-market

Injection pen market is segmented into type, therapy, and end user. Based on the type, injection pen market is classified into disposable and reusable pens. Disposable injection pen segment is expected to grow significantly. On the basis of therapy, injection pen market is segmented into diabetes, growth hormone therapy, fertility, osteoporosis, and other therapies. Diabetes segment is expected to experience a rapid growth. Based on the end user, the injection pen market is fragmented into home care and hospitals. Home care segment is expected to dominate over the forecast period.

Europe, North America, Asia Pacific, the Middle East & Africa, and Latin America are the main regional segments of the global injection pen market over the forecast period. North America is expected to dominate the injection pen with a major market share due to the presence of developed countries over the forecast period. Europe is expected to closely follow North America in terms of growth owing to technological advancement. The Asia Pacific is the fastest growing region over the forecast period owing to the large patient pool coupled with economic development. Latin America and the Middle East and Africa are expected to expand slowly over the forecast period owing to the government initiatives. All the above-mentioned factors are expected to promote the growth of the injection pen market over the forecast period.

Some of the major players of the injection pen market include Sanofi, Eli Lilly and Company, Merck & Co., Inc., Becton, Dickinson and Company (BD), Biocorp Production SA, F.Hoffman-La Roche Ltd., AstraZeneca PLC, Novo Nordisk, Pfizer, Owen Mumford Ltd., Ypsomed Holding AG, Novartis, Wilhelm Haselmeier GmbH & Co. KG, and others.

Browse the full "Injection Pen Market" report at https://www.zionmarketresearch.com/report/injection-pen-market

This report segments the global injection pen market as follows:

Global Injection Pen Market: Type Segment Analysis

Disposable
Reusable Pens
Global Injection Pen Market: Therapy Segment Analysis

Growth Hormone Therapy
Osteoporosis
Fertility
Diabetes
Other Therapies

Global Injection Pen Market: End-User Segment Analysis

Hospitals
Home care

Global Injection Pen Market: Regional Segment Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa